To require the Secretary of Health and Human Services to take no further action on proposed regulation relating to the use of chlorofluorocarbons in metered-dose inhalers.
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Nov 8, 1997)
Requires, in complying with specified provisions of the Clean Air Act and the Montreal Protocol on Substances that Deplete the Ozone Layer regarding chlorofluorocarbons (CFCs), that any regulations under which the essential use designations may be removed to phase out allowances for drug products require certification to the Congress that alternatives to inhalers are available that, for all user populations, are comparable in safety and effectiveness, therapeutic indications, dosage strength, cost, and retail availability. Requires withdrawal of a specified proposed rulemaking concerning CFCs in metered-dose inhalers. Regulates issuance of another proposal.
What just happenedNov 20, 1997
Referred to the Subcommittee on Health and Environment.
Who’s behind it
- Introduced in HouseNov 8, 1997
- Nov 20, 1997CommitteeH11000
Referred to the Subcommittee on Health and Environment.
Health and Environment Subcommittee - Nov 9, 1997IntroReferralB00100
Sponsor introductory remarks on measure. (CR E2283)
- Nov 8, 1997IntroReferralH11100
Referred to the House Committee on Commerce.
Energy and Commerce Committee - Nov 8, 1997IntroReferralIntro-H
Introduced in House
- Nov 8, 1997IntroReferral1000
Introduced in House